GlassScriptPhysician profile
Kent A Zocchi
NPI 1629028733
$2,091.01
in general payments reported to CMS, 2019-2025
16 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $55.33 · 2021: $163 · 2022: $121 · 2023: $585 · 2024: $541 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $637.92 | 2019-2025 | Eylea Hd, Eylea |
| Alimera Sciences, INC. | $227.89 | 2023-2024 | Yutiq, Iluvien |
| Abbvie INC. | $225.76 | 2019-2025 | Ozurdex |
| Carl Zeiss Meditec, INC. | $205.52 | 2019 | |
| Genentech USA, INC. | $192.49 | 2019-2024 | Vabysmo |
| Alcon Vision LLC | $125.43 | 2025 | Ngenuity, Unity |
| Apellis Pharmaceuticals, INC. | $121.79 | 2023-2025 | Syfovre |
| Bausch & Lomb Americas INC. | $95.27 | 2023 | Xipere, Visudyne |
| Mallinckrodt Hospital Products INC. | $57.20 | 2023-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $45.58 | 2019-2020 | |
| Allergan, INC. | $41.55 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $28.33 | 2021 | |
| Coherus Oncology, INC. | $23.25 | 2023 | |
| Astellas Pharma US INC | $22.23 | 2025 | Izervay |
| Vyera Pharmaceuticals, LLC | $21.22 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $19.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Zocchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.